Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

BACKGROUND: Clinically significant anxiety and depression are common in patients with cancer, and are associated with poor psychiatric and medical outcomes. Historical and recent research suggests a role for psilocybin to treat cancer-related anxiety and depression. METHODS: In this double-blind, pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Stephen, Bossis, Anthony, Guss, Jeffrey, Agin-Liebes, Gabrielle, Malone, Tara, Cohen, Barry, Mennenga, Sarah E, Belser, Alexander, Kalliontzi, Krystallia, Babb, James, Su, Zhe, Corby, Patricia, Schmidt, Brian L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367551/
https://www.ncbi.nlm.nih.gov/pubmed/27909164
http://dx.doi.org/10.1177/0269881116675512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367551/
https://www.ncbi.nlm.nih.gov/pubmed/27909164
http://dx.doi.org/10.1177/0269881116675512

Ejemplares similares